Reuters: Cholesterol drug not linked to cancer

[NaDiNe]

Cholesterol drug not linked to cancer
      
   
      

NEW YORK (Reuters Health) - Contrary to a recent report, findings from a large-scale study suggest that the cholesterol-lowering drug Zetia (also known by the generic name, ezetimibe) does not increase the risk of cancer. This also holds true for Vytorin, which combines ezetimibe with simvastatin, another cholesterol-lowering agent.<div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login